Virtu Financial LLC Obs Eva Sa Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.14 - $0.21 $6,819 - $10,229	48,711 Added 80.7%	109,073 $16,000
Q3 2022 Nov 07, 2022	SELL	$0.14 - $1.83 $6,242 - $81,597	-44,589 Reduced 42.49%	60,362 $9,000
Q2 2022 Aug 09, 2022	BUY	$1.34 - $2.08 $114,306 - $177,430	85,303 Added 434.16%	104,951 $169,000
Q1 2022 May 17, 2022	BUY	$1.1 - $2.17 $21,612 - $42,636	19,648 New	19,648 $30,000
Q3 2021 Nov 12, 2021	SELL	$2.47 - $3.34 $64,131 - $86,719	-25,964 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.56 - $3.35 $66,467 - $86,979	25,964 New	25,964 $79,000
Q1 2021 May 19, 2021	SELL	$2.01 - $5.05 $159,865 - $401,651	-79,535 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.89 - $2.55 $150,321 - $202,814	79,535 New	79,535 $165,000
Q3 2020 Dec 11, 2020	SELL	$2.46 - $6.15 $116,441 - $291,104	-47,334 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$2.01 - $5.95 $95,141 - $281,637	47,334 New	47,334 $279,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.